Hyperfine Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain ImagesBusiness Wire • 07/17/24
Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024Business Wire • 07/11/24
Hyperfine Expands European Market Reach with Additional Strategic Distributor PartnersBusiness Wire • 07/10/24
Clinical Research Using Swoop® System for Alzheimer's Disease Monitoring to be Presented at the 2024 Alzheimer's Association International ConferenceBusiness Wire • 06/25/24
Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024Business Wire • 06/03/24
Hyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to IndiaBusiness Wire • 05/28/24
Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European MarketsBusiness Wire • 05/10/24
Will Hyperfine, Inc. (HYPR) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 05/06/24
Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024Business Wire • 04/29/24
Down -19% in 4 Weeks, Here's Why Hyperfine (HYPR) Looks Ripe for a TurnaroundZacks Investment Research • 04/25/24
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical ConditionsBusiness Wire • 04/23/24
Leading Institutions Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in CARE PMR StudyBusiness Wire • 04/17/24
Hyperfine, Inc. Collaborates with King's College London to Demonstrate the Swoop® System and UNITY Project to The Princess RoyalBusiness Wire • 03/12/24